Glycaemic Control and Management in Adult Type 2 Diabetes Patients Previously Treated With Premix Insulins and Initiating Treatment With IDegLira in Routine Clinical Practice in Croatia: A 36-week Single Arm, Prospective, Multi-centre, Non-interventional Study
Latest Information Update: 04 Nov 2022
At a glance
- Drugs Insulin degludec/liraglutide (Primary)
- Indications Type 2 diabetes mellitus
- Focus Therapeutic Use
- Acronyms GLIDE
- Sponsors Novo Nordisk
Most Recent Events
- 28 Oct 2022 Status changed from not yet recruiting to withdrawn prior to enrolment.
- 03 Aug 2022 New trial record